Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

NCT03349242 is registered in ClinicalTrials.gov with MeiraGTx UK II Ltd as lead sponsor.

NCT NCT03349242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)
Lead sponsor
MeiraGTx UK II Ltd
Phase
Observational
Overall status
Completed
Start date
December 19, 2017
Completion date
April 19, 2024
Enrollment
140 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa